美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=ATAZANAVIR"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
ATAZANAVIR SULFATE 208177 001 ANDA ATAZANAVIR SULFATE CAPSULE;ORAL EQ 150MG BASE No No 2018/09/24 2018/09/24 MYLAN Discontinued
ATAZANAVIR SULFATE 208177 002 ANDA ATAZANAVIR SULFATE CAPSULE;ORAL EQ 200MG BASE No No 2018/09/24 2018/09/24 MYLAN Discontinued
ATAZANAVIR SULFATE 208177 003 ANDA ATAZANAVIR SULFATE CAPSULE;ORAL EQ 300MG BASE No No 2018/09/24 2018/09/24 MYLAN Discontinued
ATAZANAVIR SULFATE 209717 001 ANDA ATAZANAVIR SULFATE CAPSULE;ORAL EQ 100MG BASE No No 2020/06/01 2020/06/01 AMNEAL Discontinued
ATAZANAVIR SULFATE 209717 002 ANDA ATAZANAVIR SULFATE CAPSULE;ORAL EQ 150MG BASE No No 2020/06/01 2020/06/01 AMNEAL Prescription
ATAZANAVIR SULFATE 209717 003 ANDA ATAZANAVIR SULFATE CAPSULE;ORAL EQ 200MG BASE No No 2020/06/01 2020/06/01 AMNEAL Prescription
ATAZANAVIR SULFATE 209717 004 ANDA ATAZANAVIR SULFATE CAPSULE;ORAL EQ 300MG BASE No No 2020/06/01 2020/06/01 AMNEAL Prescription
ATAZANAVIR SULFATE 210575 001 ANDA ATAZANAVIR SULFATE CAPSULE;ORAL EQ 150MG BASE No No 2020/06/04 2020/06/04 ZYDUS PHARMS Discontinued
ATAZANAVIR SULFATE 210575 002 ANDA ATAZANAVIR SULFATE CAPSULE;ORAL EQ 200MG BASE No No 2020/06/04 2020/06/04 ZYDUS PHARMS Discontinued
ATAZANAVIR SULFATE 210575 003 ANDA ATAZANAVIR SULFATE CAPSULE;ORAL EQ 300MG BASE No No 2020/06/04 2020/06/04 ZYDUS PHARMS Discontinued
ATAZANAVIR SULFATE 212579 001 ANDA ATAZANAVIR SULFATE CAPSULE;ORAL EQ 150MG BASE No No 2021/04/30 2021/04/30 LAURUS Prescription
ATAZANAVIR SULFATE 212579 002 ANDA ATAZANAVIR SULFATE CAPSULE;ORAL EQ 200MG BASE No No 2021/04/30 2021/04/30 LAURUS Prescription
ATAZANAVIR SULFATE 212579 003 ANDA ATAZANAVIR SULFATE CAPSULE;ORAL EQ 300MG BASE No No 2021/04/30 2021/04/30 LAURUS Prescription
ATAZANAVIR SULFATE 212278 001 ANDA ATAZANAVIR SULFATE CAPSULE;ORAL EQ 150MG BASE No No 2022/02/02 2022/02/02 HETERO LABS LTD III Prescription
ATAZANAVIR SULFATE 212278 002 ANDA ATAZANAVIR SULFATE CAPSULE;ORAL EQ 200MG BASE No No 2022/02/02 2022/02/02 HETERO LABS LTD III Prescription
ATAZANAVIR SULFATE 212278 003 ANDA ATAZANAVIR SULFATE CAPSULE;ORAL EQ 300MG BASE No No 2022/02/02 2022/02/02 HETERO LABS LTD III Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database